Leaving No One Behind: Culture and Context Count in Tailoring Hepatitis Interventions [Hosted by NIMHD]

Leaving No One Behind: Culture and Context Count in Tailoring Hepatitis Interventions [Hosted by NIMHD]

June 16 2022
03:00 PM
Webinar series
NIH Research Advancing Hepatitis Elimination
NIMHD webinar

Program

Opening remarks

  • Dr. Eliseo Perez-Stable, Director, NIMHD

Presentations:

  • Dr. Ponni Perumalswami, Associate Professor of Gastroenterology and Hepatology, University of Michigan | Community-Based Interventions to Address Health Disparities and Advance Hepatitis Elimination

  • Dr. Janice Y. Tsoh, Professor of Psychiatry and Behavioral Sciences, UCSF Weill Institute for Neurosciences, University of California San Francisco | Health Within Reach - An Interactive Video Patient Education Intervention to Increase Hepatitis B & C Screening Among Asian Americans in Primary Care

  • Dr. Barbara J. Turner, Professor of Clinical Medicine, Keck School of Medicine of the University of Southern California | Implementation of a Complex Primary Care Intervention to Diagnose and Treat HCV in Low Income Latinx Patients

Panel Discussion

  • Dr. Seun Falade-Nwulia, Johns Hopkins University

 

Webinar description

Populations at highest risk for acquiring hepatitis B and C viral (HBV and HCV) infection, or developing serious complications from infection, also experience structural racism, stigma, and discrimination through disparities in healthcare access and other barriers that may lead to lower rates of screening and treatment and higher burden of disease in these underserved populations. Thus, HBV and HCV elimination efforts have provided inconsistent and inequitable outcomes, and health disparities for HBV and HCV persist. In this webinar, researchers working directly with racial and ethnic communities that experience disparate hepatitis outcomes will present models of care and interventions to address hepatitis health disparities. Appropriately tailored interventions that meet the context and culture of each community can ensure HBV and HCV elimination includes all populations in the United States.